01LABS@Hong Kong, a Shanghai-Hong Kong innovation incubator, has officially commenced operations. The incubator was jointly established by China-based Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607; HKG: 2607; SPH), Shanghai Biopharmaceutical Frontier Industry Innovation Center Co., Ltd, a subsidiary of SPH, and the Hong Kong Science & Technology Parks Corporation (HKSTPC).
Specializing in cell and gene therapy, autoimmune disease, anti-aging, and other areas, the 01LABS@Hong Kong incubator is designed to host biopharmaceutical technology innovation teams and projects from around the world. The three entities agreed to collaborate in the biomedicine field in August 2022.- Flcube.com
